For the tasks of filling and packaging vials , Moderna entered into contracts with in the United States and Laboratorios Farmacéuticos Rovi in Spain.
Several experts question whether the omicron-specific booster will even be needed in the second half of 2022.
Content is fact checked after it has been edited and before publication.
Any adult eligible for a booster can get any of the available brands of coronavirus vaccines.
The incidence rate for local adverse erythema is about 10.
Pharmaceutical Technology Weekly Roundup A weekly roundup of the latest news and analysis, sent every Friday.